Communitas Capital
Early-stage venture capital firm investing in B2B SaaS and technology companies. Makes selective investments in healthcare technology and life sciences data companies, including AI-driven platforms for life sciences research.
Location
Boston, USA
Founded
2015
AUM
$150M+
Investment Range
$1M - $10M
Portfolio Companies
1
Focus
generalist
Fund Stages
seed, series-a, series-b
Investment Thesis
Communitas Capital invests in early-stage B2B technology companies with a focus on enterprise software and data platforms. In healthcare, they back companies using data and AI to transform life sciences research, drug discovery, and healthcare delivery.
Team
Partners / Managing Directors (Health & Bio Focus)
- Andy Palmer - General Partner
- Peter Levine - Venture Partner
Other Key Team Members
- Investment team with B2B enterprise software expertise
Focus Areas
- B2B SaaS
- Enterprise Software
- Healthcare Technology
- Life Sciences Data
- AI/ML Platforms
- Data Infrastructure
Notable Exits
- Portfolio companies in growth stage
- Focus on B2B technology platforms
Portfolio Companies (Healthcare)
- Pheno.ai (AI for life sciences)
Sources
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Pheno.AI | Tel Aviv, Israel | 2019 | ai-drug-discoveryhealthcare-platform+2 |